Salarius Pharmaceuticals's total assets for Q3 2025 were $6.10M, an increase of 337.76% from the previous quarter. SLRX total liabilities were $1.85M for the fiscal quarter, a -16.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.